Stay updated on AK104 in NSCLC Phase II Clinical Trial

Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 in NSCLC Phase II Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s footer revision/version number is updated from **v3.5.2** to **v3.5.3** for the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-04-24T06:20:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Record History shows Revision: v3.5.2 added and Revision: v3.5.0 removed. This indicates a minor version update to the study record.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:49.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    The Record History adds a new revision v3.5.0 and removes the previous revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:31.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.4.3, was added to the study record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:36:29.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.2) and removed prior notices about funding and operating status. These are administrative updates to the page and do not affect trial data or current study status.
    Difference
    0.9%
    Check dated 2026-02-11T14:36:58.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a site-wide funding notice and a new revision tag (v3.4.1); the previous revision (v3.4.0) is shown as a deletion.
    Difference
    0.9%
    Check dated 2026-02-04T10:50:57.000Z thumbnail image

Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.